3042 companies

NUTEX Investments

Market Cap: Ft2.6b

Provides health preserving, health improving, dietary supplement, and cosmetic products in Hungary and internationally.

NUTEX

Ft16.40

7D

0%

1Y

-13.5%

Cambium Bio

Market Cap: AU$11.9m

A clinical-stage regenerative medicine company, focuses on developing biologics for ophthalmology and tissue repair applications.

CMB

AU$0.52

7D

3.0%

1Y

35.1%

RBC Bioscience

Market Cap: NT$236.2m

Researches, develops, manufactures, and sells reagents and devices for life science and molecular diagnosis in Europe, the United States, Asia, Taiwan, Africa, and Australia.

6848

NT$18.20

7D

1.4%

1Y

2.7%

Actavia Life Sciences

Market Cap: US$7.7m

A leukemia-focused biotechnology company, engages in developing therapeutics for the treatment of acute myeloid leukemia (AML) and other forms of leukemia and lymphoma.

RASP

US$0.01

7D

0%

1Y

n/a

N4 Pharma

Market Cap: UK£5.7m

A specialist pharmaceutical company, develops nanoparticle silica delivery systems to enhance the cellular delivery and potency of cancer treatments and vaccines in the United Kingdom.

N4P

UK£0.0069

7D

38.0%

1Y

25.5%

Welcure Drugs and Pharmaceuticals

Market Cap: ₹680.9m

Engages in trading of agriculture products in India.

524661

₹6.06

7D

-17.9%

1Y

-21.2%

Biofil Chemicals and Pharmaceuticals

Market Cap: ₹679.8m

Engages in manufacturing and trading of pharmaceuticals in India.

524396

₹41.77

7D

-3.6%

1Y

-48.3%

NuCana

Market Cap: US$7.6m

A clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer.

NCNA

US$4.01

7D

8.7%

1Y

-99.2%

Galmed Pharmaceuticals

Market Cap: US$7.6m

A biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases.

GLMD

US$1.40

7D

-4.1%

1Y

-80.3%

AIM ImmunoTech

Market Cap: US$7.6m

An immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States.

0A4Y

US$2.79

7D

7.8%

1Y

-89.9%

Y.B Urban Renewal - Residential Development

Market Cap: ₪25.3m

Engages in the cultivation and production of medical cannabis.

YBRD

₪6.15

7D

-6.1%

1Y

-62.1%

American Films

Market Cap: US$7.5m

Does not have significant operations.

AMFL

US$0.12

7D

18.4%

1Y

-24.9%

Entero Therapeutics

Market Cap: US$7.5m

A clinical-stage biopharmaceutical company, engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases.

ENTO

US$4.75

7D

-7.9%

1Y

360.7%

AFC Agro Biotech

Market Cap: ৳910.2m

Engages in the manufacture and sale of bio-pharmaceuticals and bio-chemical products in Bangladesh.

AFCAGRO

৳7.90

7D

1.3%

1Y

-17.7%

Concord Drugs

Market Cap: ₹662.0m

Engages in the manufacture and sale of pharmaceutical formulations in India.

538965

₹66.20

7D

-2.6%

1Y

77.6%

Aton

Market Cap: €6.4m

Operates as a bioscience company in France.

ALTAO

€0.0078

7D

2.6%

1Y

-44.3%

Spago Nanomedical

Market Cap: SEK 70.0m

A clinical phase nanomedicine company, engages in the development of nanomedicines for cancer diagnostics and treatment primarily in Sweden.

SPAGO

SEK 0.20

7D

-4.3%

1Y

-19.0%

Alzamend Neuro

Market Cap: US$7.4m

A clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders.

ALZN

US$2.41

7D

0.4%

1Y

-84.9%

Ayala Pharmaceuticals

Market Cap: US$7.4m

A clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers.

ADXS

US$0.091

7D

77.9%

1Y

94.3%

Accretion Pharmaceuticals

Market Cap: ₹653.6m

Engages in the manufacturing and marketing of pharmaceutical products in India.

ACCPL

₹58.80

7D

-9.3%

1Y

n/a

Godavari Drugs

Market Cap: ₹651.5m

Manufactures and sells active pharmaceutical ingredients (APIs), drug intermediaries, and fine chemicals in India.

530317

₹86.51

7D

1.2%

1Y

-30.0%

AcouSort

Market Cap: SEK 69.0m

A technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets.

ACOU

SEK 3.26

7D

0.3%

1Y

-77.9%

Adial Pharmaceuticals

Market Cap: US$7.3m

A clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders.

ADIL

US$0.34

7D

-1.7%

1Y

-65.9%

Brainstorm Cell Therapeutics

Market Cap: US$7.3m

A biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases.

BCLI

US$0.71

7D

1.5%

1Y

-78.7%

Innovotech

Market Cap: CA$10.0m

Provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally.

IOT

CA$0.20

7D

-4.8%

1Y

48.1%

Cardio Diagnostics Holdings

Market Cap: US$7.2m

Develops and commercializes epigenetics-based clinical tests for cardiovascular disease.

CDIO

US$4.07

7D

2.0%

1Y

-38.1%

Christina Lake Cannabis

Market Cap: CA$9.9m

A license cannabis producer, engages in the research and development, cultivation, processing, production, and sale of cannabis in Canada.

CLC

CA$0.04

7D

-11.1%

1Y

14.3%

Vista Pharmaceuticals

Market Cap: ₹630.3m

Manufactures and sells pharmaceutical, medical, and veterinary preparations in India and internationally.

524711

₹10.24

7D

7.8%

1Y

-25.3%

Percheron Therapeutics

Market Cap: AU$10.9m

Engages in the research and development of novel antisense pharmaceuticals for cancer and rare diseases in Australia.

PER

AU$0.01

7D

0%

1Y

-90.0%

Palisade Bio

Market Cap: US$7.0m

A clinical-stage biopharmaceutical company, focuses on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases.

PALI

US$0.90

7D

49.7%

1Y

-73.2%

OLIPASS

Market Cap: ₩9.6b

A biotech company, focuses on developing therapeutic products in South Korea.

A244460

₩1,651.00

7D

0%

1Y

-70.0%

Pure Biologics

Market Cap: zł25.6m

A biopharmaceutical company, engages in the research and development of biological drugs and non-systematic therapies in the field of immuno-oncology, autoimmunology, and rare neurological diseases.

PUR

zł6.28

7D

-4.6%

1Y

-68.9%

Silo Pharma

Market Cap: US$7.0m

Silo Pharma Inc. operates as a developmental stage biopharmaceutical company.

SILO

US$0.77

7D

12.6%

1Y

-29.3%

Remedium Lifecare

Market Cap: ₹616.9m

A pharmaceutical company, trades and sells active pharmaceutical ingredients (API) and intermediates in India and internationally.

539561

₹1.53

7D

0.7%

1Y

-82.8%

Proteome Sciences

Market Cap: UK£5.2m

Provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally.

PRM

UK£0.018

7D

-42.3%

1Y

-41.7%

Soligenix

Market Cap: US$6.9m

A late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States.

SNGX

US$1.20

7D

-55.4%

1Y

-68.1%

Page 67 of 85